{"id":"W2603056587","doi":"10.1200/jco.2014.32.15_suppl.1058","title":"Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel (WP) or eribulin (E) followed by doxorubicin and cyclophosphamide (AC) in women with locally advanced HER2-negative breast cancer (LABC): NSABP FB-9.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Eribulin; Taxane; Febrile neutropenia; Mucositis; Neutropenia; Anthracycline; Clinical endpoint; Cyclophosphamide; Gastroenterology; Chemotherapy; Surgery; Oncology; Cancer; Metastatic breast cancer; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002242673,0.001950991,0.002281512,0.0004740147,0.0004720276,0.000944656,0.001132259,0.001756825,0.01121827],"category_scores_gemma":[0.00222857,0.0008761266,0.0009960604,0.0004517841,0.001570772,0.001194324,0.00053835,0.003568659,0.001507002],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001087878,"about_ca_system_score_gemma":0.002143781,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001034513,"about_ca_topic_score_gemma":0.002639328,"domain_scores_codex":[0.9993854,0.0003604475,0.00002904205,0.00009465202,0.00003614235,0.00009431061],"domain_scores_gemma":[0.998414,0.0003671184,0.0003414225,0.0001154724,0.0000767266,0.0006851434],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9674118,0.02217286,0.0005269056,0.0001851729,0.000180054,0.00003381959,0.00003430824,0.0003639046,0.001864661,0.00009532183,0.0006969702,0.006434347],"study_design_scores_gemma":[0.9030098,0.09518991,0.0006198498,0.00001300621,0.00009105895,0.00002011646,0.00001500297,0.0003313871,0.0002296698,0.00009021816,0.0003836101,0.000006279407],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9757675,0.001499821,0.0007635377,0.001103009,0.000770952,0.0153314,0.001367821,0.0001221931,0.003273686],"genre_scores_gemma":[0.962983,0.001749487,0.002645668,0.0021777,0.0005945219,0.02146866,0.002188734,0.00003110365,0.006161086],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01121827,"threshold_uncertainty_score":0.03752887,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05818724985628228,"score_gpt":0.4897362801187247,"score_spread":0.4315490302624425,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}